ANG Lifesciences Stock Analysis

<div class='circular--portrait' style='background:#006400;color: #FFE4E1;font-size:4em;padding-top: 25px;;'>AL</div>
Is it time to take up ANG Lifesciences? ANG Lifesciences Stock analysis can help investors discover the best opportunities and time the market in virtually any economy. Find the stocks trading at a discount of their intrinsic value will give you an edge in creating a market-bitting portfolio. The current indifference towards the small price fluctuations of ANG Lifesciences India could raise concerns from investors as the firm closed today at a share price of 0.0 on very low momentum in volume. The company executives did not add any value to ANG Lifesciences investors in June. However, most investors can still diversify their portfolios with ANG Lifesciences India to hedge their inherited risk against high-volatility market scenarios. The stock standard deviation of daily returns for 30 days investing horizon is currently very low. The very small Stock volatility is a good signal to investors with longer term investment horizons. Check out Trending Equities.

Search Stock Analysis

 
Refresh
The ANG Lifesciences Stock analysis interface makes it easy to digest most current publicly released information about ANG Lifesciences as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. ANG Lifesciences stock analysis module also helps to analyze ANG Lifesciences price relationship with some important fundamental indicators such as market cap and management efficiency.

ANG Lifesciences Stock Analysis Notes

The company has price-to-book (P/B) ratio of 0.57. Some equities with similar Price to Book (P/B) outperform the market in the long run. ANG Lifesciences India recorded earning per share (EPS) of 10.9. The entity had not issued any dividends in recent years. ANG Lifesciences India Limited, a pharmaceutical company, manufactures and markets finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials in India. ANG Lifesciences India Limited was founded in 2006 and is based in Amritsar, India. ANG Lifesciences is traded on Bombay Stock Exchange in India. For more info on null please contact the company at 91 18 3513 3455 or go to http://www.anglifesciences.com.

ANG Lifesciences India Investment Alerts

ANG Lifesciences is not yet fully synchronised with the market data
ANG Lifesciences has some characteristics of a very speculative penny stock
ANG Lifesciences has high likelihood to experience some financial distress in the next 2 years
The company has 186.92 Million in debt which may indicate that it relies heavily on debt financing

Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 156.97 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ANG Lifesciences's market, we take the total number of its shares issued and multiply it by ANG Lifesciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Profitablity

The company has Profit Margin (PM) of 4.64 %, which can be a sign that it executes well on its competitive strategies and has a good control over its expenditures. This is normal as compared to the sector avarege. Similarly, it shows Operating Margin (OM) of 8.4 % which suggests for every 100 dollars of sales it generated a net operating income of 0.08.

Management Efficiency

The entity has return on total asset (ROA) of 8.57 % which means that it generated profit of $8.57 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 21.75 %, meaning that it generated $21.75 on every $100 dollars invested by stockholders. ANG Lifesciences management efficiency ratios could be used to measure of how well ang lifesciences india is managing its routine affairs as well as how well it utilizes its assets and manages liabilities.

ANG Lifesciences Technical and Predictive Indicators

Did you try this?

Run Sync Your Broker Now

   

Sync Your Broker

Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
All  Next Launch Module
Check out Trending Equities. Please also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page